Supporting Information

General
Melting points of all synthesized compounds were taken in a Riechert Thermover instrument and are uncorrected. The IR spectra (KBr) were recorded on PerkinElmer RXI spectrometer. 1H
NMR and 13C NMR spectra were recorded on a Bruker DRX-400 and Bruker Avance II 500 spectrometer using tetramethylsilane ( All solvents and chemicals used were purchased from Merck. 
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Spectral data of newly synthesised compounds
8-chloro-3,5-dihydro-2H-pyrazino[2,3-b]indole (3d)
Brown solid: Mp: 214-216°C, IR (KBr cm -1 ) 3127 (NH), 3027 (Ar-CH), 2845 (CH2). 1 HNMR (DMSO-d6, 400 MHz): δ 2.21 (t, 2H, CH2), 3.15 (t, 2H, CH2), 7.40-7.57 (m, 3H, Ar-H), 9.64 (s, 1H, NH). 13 C NMR (DMSO-d6, 100 MHz): δ 41. 49, 43.23, 119.71, 124.64, 130.96, 132.27, 151.49, 153.80, 160.44. Anal.Calcd (C10H9N3): C, 58.41; H, 3.92; N, 20.43. Anal. Found (C10H9N3): C, 58.39; H, 3.91; N, 20.42, (M + + 1).
2, 3-di-p-tolyl-4a,5,6,7,8,8a- -chloro-2,3,4,4a,6,11a-hexahydro-1H-indolo[2,3-b] quinoxaline (3m)
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